Sublethal necroptosis signaling promotes inflammation and liver cancer
Details
Publication Year 2023-06-12,Volume 56,Issue #7,Page 1578-1595 e8
Journal Title
Immunity
Abstract
It is currently not well known how necroptosis and necroptosis responses manifest in vivo. Here, we uncovered a molecular switch facilitating reprogramming between two alternative modes of necroptosis signaling in hepatocytes, fundamentally affecting immune responses and hepatocarcinogenesis. Concomitant necrosome and NF-κB activation in hepatocytes, which physiologically express low concentrations of receptor-interacting kinase 3 (RIPK3), did not lead to immediate cell death but forced them into a prolonged "sublethal" state with leaky membranes, functioning as secretory cells that released specific chemokines including CCL20 and MCP-1. This triggered hepatic cell proliferation as well as activation of procarcinogenic monocyte-derived macrophage cell clusters, contributing to hepatocarcinogenesis. In contrast, necrosome activation in hepatocytes with inactive NF-κB-signaling caused an accelerated execution of necroptosis, limiting alarmin release, and thereby preventing inflammation and hepatocarcinogenesis. Consistently, intratumoral NF-κB-necroptosis signatures were associated with poor prognosis in human hepatocarcinogenesis. Therefore, pharmacological reprogramming between these distinct forms of necroptosis may represent a promising strategy against hepatocellular carcinoma.
Publisher
Cell Press
Keywords
Hcc; Mlkl; Nf-κb; Rip1; Rip3; Ripk1; Ripk3; Traf2; intravital imaging; undead cells
Research Division(s)
Inflammation
PubMed ID
37329888
Open Access at Publisher's Site
https://doi.org/10.1016/j.immuni.2023.05.017
Terms of Use/Rights Notice
Refer to copyright notice on published article.


Creation Date: 2023-06-30 02:16:29
Last Modified: 2023-07-21 09:57:46
An error has occurred. This application may no longer respond until reloaded. Reload 🗙